C14H16N2O6
Neat
308.29
+5°C
Room Temperature
1335210-34-8; GX25B7MLY7; 7-Methoxy-4-Methyl-6, 8-dioxo-3, 4, 6, 8, 12, 12a-hexahydro-2H-(1, 3)oxazino(3, 2-d)pyrido(1, 2-a)pyrazine-9-carboxylic acid, (4R, 12AS)-; 7-Methoxy-4-Methyl-6, 8-dioxo-3, 4, 6, 8, 12, 12a-hexahydro-2H-[1, 3]oxazino[3, 2-d]pyrido[1, 2-a]pyrazine-9-carboxylic acid, (4R, 12AS)-; RefChem:1074469; (4R, 12aS)-7-Methoxy-4-Methyl-6, 8-dioxo-3, 4, 6, 8, 12, 12a-hexahydro-2H-[1, 3]oxazino[3, 2-d]pyrido[1, 2-a]pyrazine-9-carboxylic acid; (4R, 12AS)-7-methoxy-4-methyl-6, 8-dioxo-3, 4, 6, 8, 12, 12a-hexahydro-2H-pyrido[1', 2':4, 5]pyrazino[2, 1-b][1, 3]oxazine-9-carboxylic acid; MFCD28978321; (3S, 7R)-11-Methoxy-7-methyl-9, 12-dioxo-4-oxa-1, 8-diazatricyclo[8.4.0.03, 8]tetradeca-10, 13-diene-13-carboxylic acid; Dolutegravir Impurity 46; SCHEMBL15084338; KGWJKKUSXSBPSK-APPZFPTMSA-N; AC-30856; SY272744; F11521; F982638; (4R, 12aS)-3, 4, 6, 8, 12, 12a-Hexahydro-7-methoxy-4-methyl-6, 8-dioxo-2H-pyrido[1', 2':4, 5]pyrazino[2, 1-b][1, 3]oxazine-9-carboxylic acid; (4R, 12aS)-7-Methoxy-4-methyl-6, 8-dioxo-3, 4, 6, 8, 12, 12a-hexahydro-2H-pyrido[1 inverted exclamation mark , 2 inverted exclamation mark :4, 5]pyrazino[2, 1-b][1, 3]oxazine-9-carboxylic Acid; (4R, 12aS)-7-methoxy-4-methyl-6, 8-dioxo-3, 4, 6, 8, 12, 12a-hexahydro-2H-pyrido[1'', 2'':4, 5]pyrazino[2, 1-b][1, 3]oxazine-9-carboxylicacid; (4R, 12aS)-7-methoxy-4-methyl-6, 8-dioxo-3, 4, 6, 8, 12, 12a-hexahydro-2H-pyrido[1', 2':4, 5]pyrazino[2, 1-b][1 and 3]-oxazine-9-carboxylic acid
(3S, 7R)-11-methoxy-7-methyl-9, 12-dioxo-4-oxa-1, 8-diazatricyclo[8.4.0.03, 8]tetradeca-10 and 13-diene-13-carboxylic acid
InChI=1S/C14H16N2O6/c1-7-3-4-22-9-6-15-5-8(14(19)20)11(17)12(21-2)10(15)13(18)16(7)9/h5,7,9H,3-4,6H2,1-2H3,(H,19,20)/t7-,9+/m1/s1